Granahan Investment Management, LLC Genfit S.A. Transaction History

Granahan Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$5.2 - $22.0 $1.03 Million - $4.36 Million	-198,175 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$10.95 - $20.76 $14,508 - $27,507	-1,325 Reduced 0.66%	198,175 $2.93 Million
Q4 2019 Feb 14, 2020	SELL	$13.55 - $20.14 $2,642 - $3,927	-195 Reduced 0.1%	199,500 $3.97 Million
Q3 2019 Nov 15, 2019	BUY	$14.92 - $19.94 $126,745 - $169,390	8,495 Added 4.44%	199,695 $3.48 Million
Q2 2019 Aug 14, 2019	SELL	$19.74 - $25.65 $174,699 - $227,002	-8,850 Reduced 4.42%	191,200 $3.78 Million
Q1 2019 May 14, 2019	BUY	$22.17 - $24.0 $4.44 Million - $4.8 Million	200,050 New	200,050 $4.8 Million

77.7K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $211M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.